CLINICAL TRIALS PROFILE FOR TEVIMBRA
✉ Email this page to a colleague
All Clinical Trials for TEVIMBRA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT06124378 ↗ | Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer | Recruiting | First Affiliated Hospital of Guangxi Medical University | Phase 2 | 2023-11-13 | This study aims to elucidate the effects of neoadjuvant Tislelizumab combined with chemotherapy in locally advanced Microsatellite Stable (MSS) colon cancer. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TEVIMBRA
Condition Name
Clinical Trial Locations for TEVIMBRA
Clinical Trial Progress for TEVIMBRA
Clinical Trial Phase
Clinical Trial Sponsors for TEVIMBRA
Sponsor Name